← Eichor
Study identifier: NCT06872593 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Validating a Novel Driving Simulation-based MWT Against the Standard MWT in an OSA-cohort Challenged by CPAP-withdrawal

Condition: Excessive Daytime Sleepiness · Obstructive Sleep Apnea (OSA) · CPAP Treatment  ·  Sponsor: Stefan Lakämper

PhaseNA
Planned participants54
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersYes

About this study

In brief, the proposed study will evaluate a recently proposed naturalistic, driving simulation test to identify and measure sleepiness behind the wheel, one of the most underestimated causes of road accidents. The proposed test offers higher ecological validity and might complement somnological tests that are standard, but rarely performed. Thus, the test might provide traffic medicine and sonologists with an effective tool, that can also directly convey the risks of excessive daytime sleepiness to drivers and thus, in combination, effectively aid in traffic medicine's mandate to avoid preventable road fatalities. Excessive daytime sleepiness (EDS) is a symptomatic condition resulting from too little or compromised sleep, caused by psycho-social stress (shiftwork, lifestyle) or medical conditions (obstructive sleep apnoea (OSA), narcolepsy). Driving with untreated EDS might lead to sleepy/drowsy driving and microsleep, which is considered to be one of the highest-ranking causes of road accidents. Sleepiness and its dangers on the wheel might subjectively not be registered by the affected drivers. Also, subjective sleepiness might not correlate with somnological measurements that are also crucial for legally determining the fitness to drive (FTD). There exists a variety of partially complementary tools to evaluate the extent of EDS. Mean sleep latency obtained in the maintenance of wakefulness test (MWT) is widely, but not uniformly, considered to be one of the most objecti…

This description comes directly from the study's public registry record.

Talk to the study team

Stefan Lakämper, Dr. rer. nat.  ·  +41793789984  ·  stefan.lakaemper@irm.uzh.ch

Veronika Gambin, MSc  ·  +41797149386  ·  veronika.gambin@irm.uzh.ch

Always discuss trial participation with your own doctor first.

Locations (1)

Division of Traffic Medicine, Institute of Forensic Medicine, University of ZurichZurich, ZRH, SwitzerlandRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06872593